Study 18 of 18VIP (Vasoactive Intestinal Polypeptide) literatureCell metabolismTop journal2026
Adipokine IL-11/IL-11Ra constrains sphingolipid metabolism to limit the thermogenic capacity of beige adipocytes.
Not reported in abstract.
Where it sits
this study against the rest of the vip (vasoactive intestinal polypeptide) corpus3
Preclinical · this one
10
Observational
0
Open-label
2
Randomised
3
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the VIP (Vasoactive Intestinal Polypeptide) corpus
DEarliest siphuncle-bearing cephalopod from the early Cambrian.Nature · 2026—ARisk prediction models for malnutrition in dialysis patients in China: a systematic review and meta-analysis.Renal failure · 2026 · 41% pooled prevalence of malnutrition in dialysis patients.HumanAHealth education needs of stroke patients and caregivers: A qualitative meta-synthesis.International journal of nursing studies advances · 2026 · Not reported in abstract.HumanCTsamba-stir-fried Tiebangchui: Attenuates the toxicity of raw Tiebangchui without compromising its analgesic efficacy in Caenorhabditis elegans through TRPV channel regulation.Journal of ethnopharmacology · 2026 · Not reported in abstract.AnimalAImpact of oliceridine versus sufentanil on postoperative nausea and vomiting in patients undergoing thyroid surgery: a prospective, double-blind, randomized controlled trial.Annals of medicine · 2026 · n=232 · Incidence of PONV within 48 h postoperatively was 12% in the oliceridine group vs 28% in the sufentanil group, OR = 0.35, 95% CI: 0.17-0.72, p = 0.006.HumanBQuality of patient-reported outcome reporting and related trial characteristics in randomized controlled trials of cancer pain: A systematic review based on the CONSORT-PRO extension.Asia-Pacific journal of oncology nursing · 2026 · n=3841 · Overall mean CONSORT-PRO reporting completeness was 65.65%.Human